Jim Simons’s Anebulo Pharmaceuticals ANEB Stock Holding History

Jim Simons’s Portfolio ANEB Stock Details ANEB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,098	Closed	-$25.3K	–	3234
2025 Q4	$25.3K	Sell	25,098 -3,402	-12%	-$7.76K	﹤0.01%	3132
2025 Q3	$71.3K	Buy	+28,500	New	+$67.1K	﹤0.01%	3299

Jim Simons's ANEB Position: Q1 2026 in Review

Jim Simons sold out of Anebulo Pharmaceuticals (ANEB) in Q1 2026, closing a stake of 25,098 shares — an estimated $25.3K sold.

Jim Simons first reported a position in ANEB in Q3 2025 and held it in 2 quarters. The position peaked at $71.3K in Q3 2025. 0 funds tracked by Wall St. Rank hold ANEB as of Q1 2026.

Jim Simons reported no remaining Anebulo Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Jim Simons sold 25,098 Anebulo Pharmaceuticals shares in Q1 2026, an estimated $25.3K.
Jim Simons first reported a position in Anebulo Pharmaceuticals in Q3 2025 and held it in 2 quarters.
Jim Simons's Anebulo Pharmaceuticals position peaked at $71.3K in Q3 2025.
0 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.